Current Studies

Curis is conducting clinical trials to evaluate the efficacy and safety of potential investigational drug in cancer. See all currently enrolling clinical trials for Curis investigational therapies in the U.S. on

An Open Label Dose Escalation Trial of CA-4948 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome - NCT04278768

A Study of CA-4948 in Patients With Relapsed or Refractory Hematologic Malignancies - NCT03328078

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients with Advanced Solid Tumor Malignancies - NCT04475523